Literature DB >> 15326109

Urokinase anchors uPAR to the actin cytoskeleton.

Audrey M Bernstein1, Roseanne S Greenberg, Lavinia Taliana, Sandra K Masur.   

Abstract

PURPOSE: To investigate the expression and localization of urokinase plasminogen activator (uPA) and its receptor (uPAR) and their interaction with the actin cytoskeleton in human corneal fibroblasts.
METHODS: Primary cultured human corneal fibroblasts were exposed to exogenous uPA to investigate its effect on the distribution of uPAR under resting conditions and in a scrape-wound model. Fluorescence microscopy, immunolocalization, immunoprecipitation, and the actin depolymerizing drug cytochalasin D were used to evaluate uPAR's interaction with the actin cytoskeleton.
RESULTS: uPA/uPAR was immunodetected in large (200 microm2) aggregates devoid of detectable F-actin. However, when uPA was added to corneal fibroblasts before fixation, a dynamic association between uPAR and the actin cytoskeleton was revealed: the uPA/uPAR complex was immunodetected throughout the surface of the plasma membrane in the form of dispersed small aggregates (0.05 microm2). Association of uPAR with actin stress fibers was visualized when FITC-labeled uPA was added to the cells. This codistribution of uPA/uPAR and actin was not detected when the cells were pretreated with the actin-depolymerizing drug, cytochalasin D. uPAR was found also in focal adhesions, the termination points of F-actin, where it colocalized with the integrin alphavbeta3 in cells migrating into a scrape wound. Coimmunoprecipitation experiments confirmed the physical association of uPAR with alphavbeta3 in fibroblasts.
CONCLUSIONS: The authors propose that uPA/uPAR ligation anchors the complex to the actin cytoskeleton and is a part of the mechanism responsible for uPA-induced cell migration in fibroblasts. Copyright Association for Research in Vision and Ophthalmology

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15326109     DOI: 10.1167/iovs.04-0030

Source DB:  PubMed          Journal:  Invest Ophthalmol Vis Sci        ISSN: 0146-0404            Impact factor:   4.799


  14 in total

1.  Urokinase receptor cleavage: a crucial step in fibroblast-to-myofibroblast differentiation.

Authors:  Audrey M Bernstein; Sally S Twining; Debra J Warejcka; Edward Tall; Sandra K Masur
Journal:  Mol Biol Cell       Date:  2007-05-16       Impact factor: 4.138

2.  Maspin increases extracellular plasminogen activator activity associated with corneal fibroblasts and myofibroblasts.

Authors:  Debra J Warejcka; Malathi Narayan; Sally S Twining
Journal:  Exp Eye Res       Date:  2011-07-27       Impact factor: 3.467

3.  Functional TRPV1 expression in human corneal fibroblasts.

Authors:  Yuanquan Yang; Hua Yang; Zheng Wang; Stefan Mergler; J Mario Wolosin; Peter S Reinach
Journal:  Exp Eye Res       Date:  2012-12-08       Impact factor: 3.467

4.  Urokinase-type plasminogen activator promotes dendritic spine recovery and improves neurological outcome following ischemic stroke.

Authors:  Fang Wu; Marcela Catano; Ramiro Echeverry; Enrique Torre; Woldeab B Haile; Jie An; Changhua Chen; Lihong Cheng; Andrew Nicholson; Frank C Tong; Jaekeun Park; Manuel Yepes
Journal:  J Neurosci       Date:  2014-10-22       Impact factor: 6.167

5.  Role of the urokinase plasminogen activator receptor in mediating impaired efferocytosis of anti-SSA/Ro-bound apoptotic cardiocytes: Implications in the pathogenesis of congenital heart block.

Authors:  Paraskevi Briassouli; Elena V Komissarova; Robert M Clancy; Jill P Buyon
Journal:  Circ Res       Date:  2010-06-17       Impact factor: 17.367

6.  A central role of plasmin in cardiac injury initiated by fetal exposure to maternal anti-Ro autoantibodies.

Authors:  Paraskevi Briassouli; Marc K Halushka; Joanne H Reed; Yair Molad; Karen Fox-Talbot; Lucas Buyon; Edwin Guzman; Achiau Ludomirsky; Robert M Clancy; Jill P Buyon
Journal:  Rheumatology (Oxford)       Date:  2013-04-18       Impact factor: 7.580

7.  Proteomics-based discovery of a novel, structurally unique, and developmentally regulated plasminogen receptor, Plg-RKT, a major regulator of cell surface plasminogen activation.

Authors:  Nicholas M Andronicos; Emily I Chen; Nagyung Baik; Hongdong Bai; Caitlin M Parmer; William B Kiosses; Mark P Kamps; John R Yates; Robert J Parmer; Lindsey A Miles
Journal:  Blood       Date:  2009-11-06       Impact factor: 22.113

8.  Urokinase-type plasminogen activator (uPA) protects the tripartite synapse in the ischemic brain via ezrin-mediated formation of peripheral astrocytic processes.

Authors:  Ariel Diaz; Paola Merino; Luis G Manrique; Lihong Cheng; Manuel Yepes
Journal:  J Cereb Blood Flow Metab       Date:  2018-06-12       Impact factor: 6.200

9.  Concentration-dependent effects of transforming growth factor β1 on corneal wound healing.

Authors:  Lingyan Wang; Chun-Ying Ko; Erin E Meyers; Benjamin S Pedroja; Nadia Pelaez; Audrey M Bernstein
Journal:  Mol Vis       Date:  2011-11-02       Impact factor: 2.367

10.  Immunohistochemical localization of urokinase-type plasminogen activator, urokinase-type plasminogen activator receptor and α2-antiplasmin in human corneal perforation: a case report.

Authors:  Koji Sugioka; Aya Kodama; Koji Yoshida; Kiyotaka Okada; Masahiko Fukuda; Yoshikazu Shimomura
Journal:  BMC Ophthalmol       Date:  2012-11-28       Impact factor: 2.209

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.